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Abstract Both glutathione (GSH) depletion and arachidonic
acid (AA) generation have been shown to regulate sphingomyelin
(SM) hydrolysis and are known components in tumor necrosis
factor K (TNFK)-induced cell death. In addition, both have
hypothesized direct roles in activation of N-sphingomyelinase
(SMase); however, it is not known whether these are independent
pathways of N-SMase regulation or linked components of a
single ordered pathway. This study was aimed at differentiating
these possibilities using L929 cells. Depletion of GSH with L-
buthionin-(S,R)-sulfoximine (BSO) induced 50% hydrolysis of
SM at 12 h. In addition, TNF induced a depletion of GSH, and
exogenous addition of GSH blocked TNF-induced SM hydro-
lysis as well as TNF-induced cell death. Together, these results
establish GSH upstream of SM hydrolysis and ceramide
generation in L929 cells. We next analyzed the L929 variant,
C12, which lacks both cytosolic phospholipase A2 (cPLA2)
mRNA and protein, in order to determine the relationship of
cPLA2 and GSH. TNF did not induce a significant drop in GSH
levels in the C12 line. On the other hand, AA alone was capable
of inducing a 60% depletion of GSH in C12 cells, suggesting that
these cells remain responsive to AA distal to the site of cPLA2.
Furthermore, depleting GSH with BSO failed to effect AA
release, but caused a drop in SM levels, showing that the defect
in these cells was upstream of the GSH drop and SMase
activation. When cPLA2 was restored to the C12 line by
expression of the cDNA, the resulting CPL4 cells regained
sensitivity to TNF. Treatment of the CPL4 cells with TNF
resulted in GSH levels dropping to levels near those of the wild-
type L929 cells. These results demonstrate that GSH depletion
following TNF treatment in L929 cells is dependent on intact
cPLA2 activity, and suggest a pathway in which activation of
cPLA2 is required for the oxidation and reduction of GSH levels
followed by activation of SMases. ß 2000 Published by Else-
vier Science B.V. on behalf of the Federation of European Bio-
chemical Societies.
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1. Introduction
The signi¢cance of apoptosis in development, wound heal-
ing, cancer pathogenesis, and cancer treatment has resulted in
its recognition as one of the most regulated programs in the
cell. Inducers of apoptosis include chemotherapeutic agents,
radiation, Fas ligand, and tumor necrosis factor K (TNFK)
[1]. Despite this multitude of inducers, there are common
themes in apoptotic signaling including activation of caspases,
generation of reactive oxygen species, and accumulation of
ceramide. Regulation of ceramide production and metabolism
in apoptosis is not well understood, partially due to the multi-
ple metabolic pathways that converge on this lipid mediator
[2,3]. Current work suggests that both activation of sphingo-
myelinases (SMases) as well as de novo ceramide synthesis
may be involved [2^6]. Several direct and indirect mechanisms
have been suggested for SMase activation including arachi-
donic acid (AA) generation and glutathione (GSH) depletion
[7^10]. Activation of cytosolic phospholipase A2 (cPLA2) by
TNF has been reported by a variety of laboratories, and has
been suggested as a key factor in allowing TNF to induce
death [11^13]. TNF has also been demonstrated to induce
oxidant stress [14,15] and to cause a drop in GSH levels which
precedes and regulates its cytotoxic e¡ects [7,16,17].
We previously established that in TNFK-treated L929 cells,
cPLA2 and AA generation acted upstream of SMase activa-
tion [10]. These results were supported using a variant L929
cell line (C12) which lacks cPLA2 and is resistant to TNF-
induced death [18,19]. However, how AA then activates
SMase was not understood. Both direct and indirect mecha-
nisms were possible. Early work revealed that exogenous ad-
dition of AA stimulated sphingomyelin (SM) hydrolysis and
ceramide generation. Methyl ester and an alcohol analog
failed to have similar e¡ects, suggesting speci¢city. However,
as a variety of fatty acids were shown to have similar e¡ects
on neutral SMase. It was hypothesized that the AA e¡ect did
not require further AA metabolism to eicosanoids as such
metabolism is not possible for the other fatty acids. In addi-
tion, AA activated SMase in crude homogenates, supporting
the possibility of direct AA-mediated activation [9,20,21].
In another line of investigation, we and others showed that
GSH depletion and/or oxidation was a major mechanism for
activation of neutral SMase in MCF-7 cells and other cell
lines [7,22,23]. TNFK has been shown to result in GSH de-
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pletion, N-SMase activation, and subsequent SM hydrolysis
and ceramide accumulation. As exogenous ceramide does not
result in GSH depletion and GSH does not protect from cell
death induced by ceramide accumulation, GSH depletion is
thought to lie upstream of ceramide [7]. Furthermore, GSH
has been shown to inhibit N-SMase activity in vitro, suggest-
ing a direct interaction between GSH and N-SMase [24]. On
the other hand, some studies also suggest a direct e¡ect of
ceramide on the mitochondrial electron transport chain at
complex III leading to the generation of reactive oxygen spe-
cies and GSH depletion [25^27]. Thus, the relationship be-
tween GSH and ceramide may be cell-type speci¢c, but re-
quires further clari¢cation.
To date, both cPLA2 activation and GSH depletion have
independently been shown to be required for activation of
SMases. The goal of this study, therefore, was to determine
whether these were independent mechanisms of N-SMase reg-
ulation or, alternately, if they were linked in a common path-
way. We used murine ¢broblast L929 cells, a classic model for
TNF cytotoxic signaling, due to the exquisite sensitivity of
these cells to TNFK. One advantage of this system over
many other systems is that addition of cycloheximide or acti-
nomycin D is not required, and therefore does not confuse the
results. Moreover, the availability of the C12 variant (which
lacks cPLA2 mRNA and protein [18,19]) allows the ready
determination of the role of cPLA2. Using these tools, we
show that depletion of cellular GSH lies downstream of AA
generation, but upstream of SMase activation. These results
argue for an indirect connection between cPLA2 and SMase.
More importantly, these results establish an important con-
nection between cPLA2 activation and GSH regulation, as
they show these mediators as part of a single ordered pathway
rather than independent regulators of SMase as previously
suggested.
2. Materials and methods
2.1. Materials
Low glucose Cellgro Dulbecco’s modi¢ed Eagle’s medium, fetal calf
serum (FCS), penicillin/streptomycin, and trypsin were purchased
from Fischer Scienti¢c (Atlanta, GA, USA). FCS was heat-inactivated
at 55‡C for 30 min before use. GSH and L-buthionin-(S,R)-sulfoxi-
mine (BSO; Sigma Chemical) were dissolved in medium, and pH
corrected where necessary to 7.4. TNFK was kindly provided by Dr.
Phil Pekala (East Carolina University). [3H]Choline and [3H]AA were
obtained from NEN Technologies. C6-ceramide was a kind gift of Dr.
Alicia Bielawska, (MUSC, Charleston, SC, USA), and was dissolved
in ethanol. All other reagents were obtained from Sigma.
2.2. Cell culture
L929 cells and C12 cells were maintained in 5% FCS with 60 mg/ml
kanamycin sulfate at 37‡ in a 5% CO2 incubator. For assays, cells
were seeded at the indicated density and grown for 48^72 h. After
washing with PBS, cells were re-fed with warm medium and rested for
1 h before treatment. Unless otherwise indicated, all treatments were
performed in 5% FCS at 70^90% con£uency. All experiments were
done in duplicate with time-matched controls. Where treatments were
done in ethanol, the total concentration of ethanol remained under
0.1%. Cells treated with GSH were maintained in freshly opened
medium with 5% FCS and 25 mM HEPES.
2.3. SM measurement
Lipids were extracted utilizing the Bligh and Dyer method [28], and
SM was measured by the method of Jayadev et al. [9], followed by
normalization to phosphate.
2.4. GSH measurement
Intracellular GSH was measured by the Gri⁄th protocol [29], with
a few modi¢cations as described [24].
2.5. AA release
Cells were plated at 2U104 in 12-well plates. After a 24-h incuba-
tion, the medium was replaced and 0.5 WCi/ml [3H]AA added. Label-
ing was performed overnight. Prior to treatment, label was removed,
and fresh warm medium added. After treatment, 500 Wl of medium
was removed and counted in a scintillation counter. All samples were
in duplicate and contained time-matched controls.
2.6. Viability determination
Viability was determined using the cresyl violet assay. Brie£y, cells
were seeded in 12-well plates at 2U104/well. After 48 h incubation, the
media were replaced and cells were treated. Upon completion of treat-
ment, media were removed and cells washed twice with ice-cold PBS.
Cells were ¢xed and stained with 0.5% cresyl violet, 4% formaldehyde,
and 30% methanol. Excess stain was removed, and the ¢xed cells were
washed twice for 5 and 10 min with PBS. Dye was eluted with 33%
acetic acid, and an aliquot removed for spectrophotometric analysis at
OD600.
3. Results and discussion
3.1. E¡ects of BSO on GSH levels and SMase activity
GSH depletion has been reported to lie upstream of SM
hydrolysis in MCF-7 cells [7]. However, GSH may also be
Fig. 1. E¡ect of BSO on GSH and SM levels in L929 cells. A,B: Cells were seeded in duplicate, treated with 100 WM BSO, and harvested con-
comitantly at the indicated times. Time-matched vehicle controls were also harvested at each point. Results are from three separate experiments
and are expressed as mean þ S.D. If not visible, error bars are smaller than the diameter of the points. A: Cells treated with 100 WM BSO and
assayed for GSH at the indicated times with results expressed as percent control. B: SM hydrolysis was measured in cells treated with 100 WM
BSO at the indicated times with results expressed as percent control.
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depleted subsequent to ROS production downstream of cer-
amide e¡ects on the mitochondrial electron transport chain
[25^27]. Since cPLA2 has been shown to regulate SMase in
L929 cells, it became necessary to determine if GSH depletion
is also involved in regulating SMase in L929 cells. To examine
GSH regulation of SMase, GSH depletion was induced with
BSO, which blocks GSH production by inhibiting Q-glutamyl
cysteine synthase. In L929 cells at 6 h, 100 WM BSO reduced
GSH levels by 50%, and by 12 h 80% of total cellular GSH
was depleted (Fig. 1A). Concomitantly, BSO also induced SM
hydrolysis. Approximately 20% hydrolysis of SM was ob-
served by 6 h, and by 12 h 50% of SM was lost (Fig. 1B).
These results show that GSH depletion is su⁄cient to induce
SM hydrolysis in L929 cells as previously reported in MCF-7
cells.
3.2. E¡ects of GSH repletion on TNF-induced SM hydrolysis,
ceramide accumulation and viability
To examine if GSH depletion plays a role in response to
TNFK in L929 cells, cells were stimulated with 5 nM TNF
and assayed for GSH over a 21-h time-course (Fig. 2A).
Treatment of L929 cells with 5 nM TNF induced a sustained
loss of GSH beginning 2 h after treatment with a 20% drop
and continuing until 12 h, leveling at 30% of control values.
These results demonstrate a signi¢cant and sustained deple-
tion of GSH beginning at 2 h in L929 cells.
To determine if GSH depletion is necessary for SM hydro-
lysis, cells were pre-incubated with 5 mM GSH for 2 h prior
to treatment with TNFK. GSH repletion completely blocked
SM hydrolysis. At 12 h, TNF alone induced a 40% drop in
SM while GSH repletion totally prevented SM hydrolysis
Fig. 2. E¡ects of GSH repletion on TNF-induced SM hydrolysis, ceramide accumulation and viability. A: Cells treated with 5 nM TNF were
harvested at the indicated times and assayed for GSH. Results are from three individual experiments, each done in duplicate, and are expressed
as mean percent time-matched control values þ S.D. If not visible, error bars are smaller than the diameter of the points. B: Cells were steady-
state labeled with 0.5 WCi/ml [3H]choline for 48 h, then pre-incubated with 5 mM GSH for 2 h prior to treatment with 5 nM TNF for 12 h.
SM levels were measured as described in Section 2. Results are the average of three separate experiments þ S.D. A t-test con¢rmed GSH signi¢-
cantly protected from TNF-induced hydrolysis with *P6 0.05. C: L929 cells were treated with 5 nM TNF and 5 or 10 WM C6-ceramide (C6)
for 24 h, and harvested for GSH measurements and viability as determined using the cresyl violet assay. Results are graphed on a double y-
axis with both GSH and viability values expressed as percent vehicle control. Results are from three individual experiments, and are expressed
as mean þ S.D. D: Cells were pre-incubated with 5 mM GSH for 2 h prior to treatment with 5 mM TNF for 12 h. Viability was determined
using the cresyl violet assay, with results expressed as the average of three experiments þ S.D. A t-test con¢rmed GSH signi¢cantly protected
from TNF-induced hydrolysis with *P6 0.05.
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(Fig. 2B). These results indicate that GSH depletion is neces-
sary for TNF-induced SM hydrolysis in L929 cells.
To examine the e¡ects of ceramide on GSH levels and
viability, cells were treated with 5 and 10 WM C6-ceramide
for 24 h. TNF killed almost 90% of cells by 24 h, and pro-
duced a 70% drop in GSH, whereas both 5 and 10 WM cer-
amide killed 60% of cells with no drop in GSH levels (Fig.
2C). The observation that GSH depletion is necessary for SM
hydrolysis and ceramide generation coupled with the inability
of ceramide to deplete GSH suggest that GSH depletion lies
upstream of SM hydrolysis and ceramide generation in L929
cells.
To determine if GSH repletion protected cells from TNF-
induced cell death, cells were pre-incubated with 5 mM GSH
for 2 h prior to treatment with 5 nM TNF for 12 h. GSH
partially protected cells from cytotoxicity as determined by
the cresyl violet assay, such that with GSH repletion, viability
was restored to 80% of control compared with 40% of control
in cells treated with TNF alone (Fig. 2D). Taken together,
these results (Fig. 2C,D) show that GSH depletion is neces-
sary for TNF-induced cytotoxicity, whereas ceramide genera-
tion is su⁄cient for the decrease in viability observed in re-
sponse to TNF treatment, again suggesting that GSH
depletion lies upstream of ceramide generation in L929 cells.
3.3. Role of cPLA2 in TNF-induced depletion of GSH
Having established that GSH depletion was necessary for
TNF-induced SM hydrolysis, we next sought to investigate
whether or not there was a connection between AA produc-
tion and GSH depletion as both have been independently
shown to activate SMase [8,9,21,30]. For these studies, we
used the TNF-resistant L929 variant (C12) detective in cPLA2
[18,19]. Using this cell line, we previously demonstrated that
Fig. 3. E¡ects of cPLA2 and AA on GSH levels. A: C12 and L929 cells treated with 5 nM TNF were harvested at the indicated times and as-
sayed for GSH. Results are from four separate experiments, and are expressed as mean percent control þ S.D. B: Cells were treated with 40
and 80 WM of AA for 18 h and cells harvested for GSH measurements. Results are from three separate experiments performed in duplicate,
and are expressed as mean þ S.D. Asterisks indicate results signi¢cantly di¡erent from control as determined by t-test (P6 0.05). C: Cells la-
beled with [3H]AA were treated with 100 WM and 200 WM BSO for 8 and 24 h, and AA release determined. D: C12/neo and CPL4 cells were
seeded simultaneously and treated with 5 nM TNF over a 24-h time-course. At each time-point, GSH levels were measured. Time-matched con-
trols were used, and each point done in duplicate. Results are from three separate experiments, and are expressed as mean percent con-
trol þ S.D.
Table 1
E¡ect of repleting GSH on TNF-induced AA release
Treatment Percent control
Control 100.0 þ 4.3
5 mM GSH 94.2 þ 1.6
5 nM TNF 153.3 þ 2.0
5 nM TNF+5 mM GSH 154.4 þ 0.5
L929 cells labeled with [3H]AA were treated with 5 mM GSH for
2 h before addition of 5 nM TNF. AA release was determined after
12 h of TNF treatment. Results are representative of three separate
experiments performed in duplicate, and are expressed as mean per-
cent control þ S.D.
Table 2
E¡ect of BSO on GSH levels and SM hydrolysis in C12 cells
Control 100 WM BSO 200 WM BSO
GSH 100 þ 6.4 41.0 þ 12.3 20.0 þ 14.7
SM 100 þ 1.3 79.4 þ 1.5 71.0 þ 0.3
C12 cells were treated with BSO for 12 h and assayed for GSH and
SM as described. For SM measurements, cells were pre-labeled with
[3H]choline for 72 h. Results are representative of three separate ex-
periments performed in duplicate, and are expressed as mean per-
cent control þ S.D.
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cPLA2 was necessary for TNF-induced SMase activation in
L929 cells [10]. Although TNF induced a small sustained 20%
drop in GSH, the GSH levels did not fall to the lower values
seen in L929 cells (Fig. 3A). Therefore, cPLA2 activity is
necessary for TNF-induced GSH depletion in L929 cells.
To determine if GSH depletion was necessary for cPLA2-
mediated AA production, we measured TNF-induced AA
production with and without GSH repletion (5 mM) 2 h prior
to TNF treatment for 12 h. A 1.5-fold increase in AA pro-
duction in response to TNF was observed that was una¡ected
by GSH levels (Table 1). Therefore, while cPLA2 activity is
necessary for GSH depletion, GSH depletion is not necessary
for AA production.
To determine if the product of cPLA2 activity, AA, is not
only necessary but also su⁄cient to induce GSH depletion, we
next examined GSH levels in cells treated with 40 and 80 WM
AA for 18 h, concentrations that have been found previously
to be required for cytotoxicity [31]. Treatment with 80 WM
AA reduced GSH levels by 30% in L929 and by 60% in C12
cells (Fig. 3B). Based on these results, AA is su⁄cient for
GSH depletion in L929 cells. In addition, we observed C12
cells to be more sensitive to AA than L929 cells.
To determine if GSH depletion is su⁄cient for cPLA2 ac-
tivity and AA release, cells labeled with [3H]AA were treated
with 100 and 200 WM BSO, and AA release was determined.
There were no signi¢cant changes in AA release with GSH
depletion (Fig. 3C). As a control, we measured BSO-induced
GSH depletion and SM hydrolysis in C12 cells to con¢rm that
these parameters were normal (Table 2). Taken together, these
results demonstrate that AA production is upstream of GSH
depletion.
To further substantiate this conclusion, we hypothesized
that restoration of cPLA2 activity to C12 cells should restore
TNF-induced GSH depletion. C12/neo (vector only control
cells) and CPL4 (C12 cells transfected with cPLA2) were
seeded simultaneously and treated with 5 nM TNF. Cells
were harvested and GSH levels measured over a time-course
of 24 h. GSH levels decreased to levels comparable to those
found in wild-type L929 cells while the vector control levels
remained at 80% of control (Fig. 3D). In addition, as previ-
ously reported, CPL4 cells partially regained sensitivity to
TNF-induced cytotoxicity [10]. TNF induced 60% death in
CPL4 cells versus 15% in C12 and 85% in L929 (data not
shown). Taken together, these studies show that cPLA2 is
necessary for TNF-induced GSH depletion and subsequent
cytotoxicity in L929 cells. Therefore, cPLA2 activity lies up-
stream of GSH depletion and SM hydrolysis.
3.4. Conclusions
The ¢rst conclusion to be derived from these results is that
GSH depletion lies upstream of SM hydrolysis in L929 cells.
This is supported by the facts that (i) GSH depletion occurred
prior to SM hydrolysis; (ii) pharmacologically depleting GSH
with BSO induced SM hydrolysis, and therefore, GSH deple-
tion is su⁄cient for SM hydrolysis; (iii) exogenous GSH treat-
ment prevented TNF-induced cytotoxicity and SM hydrolysis,
and therefore, GSH depletion is necessary for SM hydrolysis;
(iv) C6-ceramide treatment does not a¡ect GSH levels, and
therefore, GSH depletion is not downstream of ceramide for-
mation. These results extend previous studies on the relation-
ship of GSH and SMase [7,22,23], and they begin to de¢ne a
general mechanism tying oxidative stress/GSH metabolism to
activation of SMases.
These studies also provide strong evidence that GSH deple-
tion in L929 cells is downstream of cPLA2 and dependent on
cPLA2 activity. Thus, C12 cells, which lack cPLA2 activity,
failed to drop GSH upon TNF stimulation. In addition, exog-
enous AA was su⁄cient to induce GSH depletion, whereas
manipulating GSH levels pharmacologically failed to a¡ect
AA levels. Most convincingly, restoring cPLA2 activity to
C12 cells also restored GSH depletion in response to TNF.
Together, these results are most consistent with GSH deple-
tion lying downstream of cPLA2, with activation of cPLA2
being required for the depletion in the levels of GSH seen in
L929 cells after TNF treatment.
These results suggest the following scenario (see Fig. 4).
TNF induces cPLA2 activation, resulting in AA release.
cPLA2 activity in turn results in GSH depletion, which, ¢-
nally, initiates SM hydrolysis. The ceramide induced by this
system then goes on to play a role in regulating cytotoxicity
[7,10,23,32].
The connection of cPLA2 to GSH leads to further questions
on possible mechanisms for this connection. The complexity
of AA signaling and metabolism o¡ers several possibilities.
AA itself may play a direct role in regulating GSH depletion,
through regulation of metabolism or uptake/e¥ux of GSH.
Other research has suggested metabolism to arachidonoyl
CoA may be involved in AAs e¡ect on SMase activity [21].
Alternatively, the eicosanoids produced from AA metabolism
may play a role. Several groups have reported a role for
lipoxygenase enzymes in TNF-induced cytotoxity [13,33^35],
and a recent report suggests lipoxygenase activity may be
important in apoptosis induced by thiol depletion [36]. An-
other option for connecting cPLA2 and GSH depletion stems
from the nature of AA metabolism. Many enzymes responsi-
ble for metabolizing AA produce hydroperoxides and other
oxidative species as by-products [37]. It is possible that these
oxidative species go on to induce the depletion of GSH, either
before or after oxidation to GSSG [38]. Transporters for both
oxidized and reduced GSH are known, and in Fas-induced
Fig. 4. Proposed scheme of TNF-induced cell death in L929 cells.
According to this scheme, TNF activates cPLA2 which then gener-
ates AA and lysophospholipids. This in turn is required for the de-
pletion of GSH, possibly as a result of oxidation of GSH. Depletion
of GSH is then required for the activation of SMase, SM hydroly-
sis, and ceramide generation. Ceramide in turn regulates many
downstream cell growth and death responses.
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GSH depletion, GSH is pumped out of the cell [39], although
the nature of the molecular species transported was not de-
termined. Thus, it is possible that persistent activation of
cPLA2 and downstream enzymes may result in an oxidative
load in the cell that results in depletion of GSH. Ongoing
studies in our laboratory are investigating these possibilities.
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